MedPath

Comparative long-term effects of depot medroxyprogesterone acetate, a levonorgestrel implant and a copper intrauterine device on depression and sexual

Not Applicable
Conditions
Mental and Behavioural Disorders
Depression ,sexual dysfunction
Registration Number
PACTR201801002743482
Lead Sponsor
Effective Care Research Unit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
291
Inclusion Criteria

¿16 to 35 years of age
¿HIV sero-negative at baseline
¿Seeking effective contraception
¿Able and willing to provide written informed consent
¿Agrees to be randomised to either the copper IUD, DMPA, or LNG implant
¿Agrees to use assigned method for 18 months
¿Agrees to follow all study requirements
¿Intends to stay in the study area for the next 18 months and willing and able to provide adequate locator information
¿If has had a recent third trimester birth, is at least 6 weeks¿ postpartum
¿Is sexually active (has had vaginal sex within the last 3 months) or has been pregnant within the last 3 months
¿Agrees not to participate in studies of drugs or vaccines or any other clinical research study while participating in this study

Exclusion Criteria

Women are not eligible to participate if they have medical contraindications to the IUD, DMPA, or LNG implant (WHO Medical Eligibility Criteria category 3 or 4),

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath